The role of redox signaling in epigenetics and cardiovascular disease

Antioxidants and Redox Signaling

Volumn 18, Issue 15, 2013, Pages 1920-1936

  Kim, Gene H ^a   Ryan, John J ^a   Archer, Stephen L ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; SUPEROXIDE DISMUTASE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL PROLIFERATION; CONGESTIVE HEART FAILURE; DISEASE PREDISPOSITION; DNA METHYLATION; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION; GENETIC RISK; HUMAN; HYPERTENSION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

CARDIOVASCULAR DISEASES; DNA METHYLATION; ENVIRONMENT; EPIGENESIS, GENETIC; HISTONES; HUMANS; OXIDATION-REDUCTION; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84876135208     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4926     Document Type: Review

References (142)

1. HeartProtection Study Collaborative Group.MRC/BHFHeart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 23-33, 2002.
2. Alkemade FE, van Vliet P, Henneman P, van Dijk KW, Hierck BP, van Munsteren JC, Scheerman JA, Goeman JJ, Havekes LM, Gittenberger-de Groot AC, van den Elsen PJ, and DeRuiter MC. Prenatal exposure to apoE deficiency and postnatal hypercholesterolemia are associated with altered cell-specific lysine methyltransferase and histone methylation patterns in the vasculature. Am J Pathol 176: 542-548, 2010.
3. Antoniades C, Antonopoulos AS, Tousoulis D, Marinou K, and Stefanadis C. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials. Eur Heart J 30: 6-15, 2009.
4. Aoyama T, Okamoto T, Nagayama S, Nishijo K, Ishibe T, Yasura K, Nakayama T, Nakamura T, and Toguchida J. Methylation in the corepromoter region of the chondromodulin-I gene determines the cell specific expression by regulating the binding of transcriptional activator Sp3. J Biol Chem 279: 28789-28797, 2004. (Pubitemid 38900164)
5. Archer SL, Marsboom G, Kim GH, Zhang HJ, Toth PT, Svensson EC, Dyck JR, Gomberg-Maitland M, Thebaud B, Husain AN, Cipriani N, and Rehman J. Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target. Circulation 121: 2661-2671, 2010.
6. Baccarelli A, and Bollati V. Epigenetics and environmental chemicals. Curr Opin Pediatr 21: 243-251, 2009.
7. Barker DJ, Osmond C, Simmonds SJ, and Wield GA. The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life. BMJ 306: 422-426, 1993. (Pubitemid 23045550)
8. Bazzano LA, Reynolds K, Holder KN, and He J. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 296: 2720-2726, 2006. (Pubitemid 44917549)
9. Beaudet AL. Allan Award lecture: rare patients leading to epigenetics and back to genetics. Am J Hum Genet 82: 1034-1038, 2008.
10. Berger SL, Kouzarides T, Shiekhattar R, and Shilatifard A. An operational definition of epigenetics. Genes Dev 23: 781-783, 2009.
11. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 321: 209-213, 1986. (Pubitemid 16016411)
12. Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, Cui H, Yu W, Rongione MA, Ekstrom TJ, Harris TB, Launer LJ, Eiriksdottir G, Leppert MF, Sapienza C, Gudnason V, and Feinberg AP. Intra-individual change over time in DNA methylation with familial clustering. JAMA 299: 2877-2883, 2008. (Pubitemid 351930887)
13. Bogaard HJ, Mizuno S, Hussaini AA, Toldo S, Abbate A, Kraskauskas D, Kasper M, Natarajan R, and Voelkel NF. Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats. Am J Respir Crit Care Med 183: 1402-1410, 2011.
14. Bogdarina I, Welham S, King PJ, Burns SP, and Clark AJ. Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circ Res 100: 520-526, 2007. (Pubitemid 46673261)
15. Bollati V, Schwartz J, Wright R, Litonjua A, Tarantini L, Suh H, Sparrow D, Vokonas P, and Baccarelli A. Decline in genomic DNA methylation through aging in a cohort of elderly subjects. Mech Ageing Dev 130: 234-239, 2009.
16. Bonnet S, Michelakis ED, Porter CJ, Andrade-Navarro MA, Thebaud B, Haromy A, Harry G, Moudgil R, McMurtry MS, Weir EK, and Archer SL. An abnormal mitochondrialhypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension. Circulation 113: 2630-2641, 2006. (Pubitemid 43948012)
17. Bowers R, Cool C, Murphy RC, Tuder RM, Hopken MW, Flores SC, and Voelkel NF. Oxidative stress in severe pulmonary hypertension. Am J Respir Crit Care Med 169: 764-769, 2004. (Pubitemid 38338929)
18. Breton CV, Byun HM, Wenten M, Pan F, Yang A, and Gilliland FD. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am J Respir Crit Care Med 180: 462-467, 2009.
19. Broadbent HM, Peden JF, Lorkowski S, Goel A, Ongen H, Green F, Clarke R, Collins R, Franzosi MG, Tognoni G, Seedorf U, Rust S, Eriksson P, Hamsten A, Farrall M, and Watkins H. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 17: 806-814, 2008. (Pubitemid 351359697)
20. Castro R, Rivera I, Struys EA, Jansen EE, Ravasco P, Camilo ME, Blom HJ, Jakobs C, and Tavares de Almeida I. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem 49: 1292-1296, 2003. (Pubitemid 36900615)
21. Cerda S, and Weitzman SA. Influence of oxygen radical injury on DNA methylation. Mutat Res 386: 141-152, 1997. (Pubitemid 27195019)
22. Chan GC, Fish JE, Mawji IA, Leung DD, Rachlis AC, and Marsden PA. Epigenetic basis for the transcriptional hyporesponsiveness of the human inducible nitric oxide synthase gene in vascular endothelial cells. J Immunol 175: 3846-3861, 2005. (Pubitemid 41292045)
23. Chan SY, and Loscalzo J. MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 9: 1072-1083, 2010.
24. Chelbi ST, Mondon F, Jammes H, Buffat C, Mignot TM, Tost J, Busato F, Gut I, Rebourcet R, Laissue P, Tsatsaris V, Goffinet F, Rigourd V, Carbonne B, Ferre F, and Vaiman D. Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia. Hypertension 49: 76-83, 2007. (Pubitemid 46360344)
25. Chen H, Yan Y, Davidson TL, Shinkai Y, and Costa M. Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. Cancer Res 66: 9009-9016, 2006. (Pubitemid 44521119)
26. Chen Z, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, Lussier-Cacan S, Chen MF, Pai A, John SW, Smith RS, Bottiglieri T, Bagley P, Selhub J, Rudnicki MA, James SJ, and Rozen R. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 10: 433-443, 2001. (Pubitemid 32181666)
27. Cho Y, Eom G, Kee H, Kim H, Choi W, Nam K, Ma J, and Kook H. Sodium valproate, a histone deacetylase inhibitor, but not captopril, prevents right ventricular hypertrophy in rats. Circ J 74: 760-770, 2010.
28. Choi JH, Nam KH, Kim J, Baek MW, Park JE, Park HY, Kwon HJ, Kwon OS, Kim DY, and Oh GT. Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 25: 2404-2409, 2005. (Pubitemid 41552662)
29. Christian RC, Liu PY, Harrington S, Ruan M, Miller VM, and Fitzpatrick LA. Intimal estrogen receptor (ER)beta, but not ERalpha expression, is correlated with coronary calcification and atherosclerosis in pre-and postmenopausal women. J Clin Endocrinol Metab 91: 2713-2720, 2006. (Pubitemid 44024642)
30. Chuang JC, and Jones PA. Epigenetics and microRNAs. Pediatr Res 61: 24R-29R, 2007. (Pubitemid 46653064)
31. Courboulin A, Paulin R, Giguere NJ, Saksouk N, Perreault T, Meloche J, Paquet ER, Biardel S, Provencher S, Cote J, Simard MJ, and Bonnet S. Role for miR-204 in human pulmonary arterial hypertension. J Exp Med 208: 535-548, 2011.
32. Cyr AR, and Domann FE. The redox basis of epigenetic modifications: from mechanisms to functional consequences. Antioxid Redox Signal 15: 551-589, 2011.
33. Dennery PA. Oxidative stress in development: nature or nurture? Free Radic Biol Med 49: 1147-1151, 2010.
34. Devlin AM, Arning E, Bottiglieri T, Faraci FM, Rozen R, and Lentz SR. Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and vascular function in mice. Blood 103: 2624-2629, 2004. (Pubitemid 38393016)
35. Dong C, Yoon W, and Goldschmidt-Clermont PJ. DNA methylation and atherosclerosis. J Nutr 132: 2406S-2409S, 2002. (Pubitemid 34848116)
36. Farha S, Asosingh K, Xu W, Sharp J, George D, Comhair S, Park M, Tang WH, Loyd JE, Theil K, Tubbs R, Hsi E, Lichtin A, and Erzurum SC. Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities. Blood 117: 3485-3493, 2011.
37. Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature 447: 433-440, 2007. (Pubitemid 46816750)
38. Fijalkowska I, Xu W, Comhair SA, Janocha AJ, Mavrakis LA, Krishnamachary B, Zhen L, Mao T, Richter A, Erzurum SC, and Tuder RM. Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells. Am J Pathol 176: 1130-1138, 2010.
39. Finkel T. Signal transduction by reactive oxygen species in non-phagocytic cells. J Leukoc Biol 65: 337-340, 1999. (Pubitemid 29109705)
40. Fish JE, Matouk CC, Rachlis A, Lin S, Tai SC, D'Abreo C, and Marsden PA. The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. J Biol Chem 280: 24824-24838, 2005. (Pubitemid 40934573)
41. Fish JE, Yan MS, Matouk CC, St Bernard R, Ho JJ, Gavryushova A, Srivastava D, and Marsden PA. Hypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histones. J Biol Chem 285: 810-826, 2010.
42. Friso S, Pizzolo F, Choi SW, Guarini P, Castagna A, Ravagnani V, Carletto A, Pattini P, Corrocher R, and Olivieri O. Epigenetic control of 11 beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension. Atherosclerosis 199: 323-327, 2008.
43. Gan Y, Shen YH, Wang J, Wang X, Utama B, and Wang XL. Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase. J Biol Chem 280: 16467-16475, 2005. (Pubitemid 40616778)
44. Gao WD, Liu Y, and Marban E. Selective effects of oxygen free radicals on excitation-contraction coupling in ventricular muscle. Implications for the mechanism of stunned myocardium. Circulation 94: 2597-2604, 1996. (Pubitemid 26403591)
45. Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E, Schwind S, Pang J, Yu J, Muthusamy N, Havelange V, Volinia S, Blum W, Rush LJ, Perrotti D, Andreeff M, Bloomfield CD, Byrd JC, Chan K, Wu LC, Croce CM, and Marcucci G. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 113: 6411-6418, 2009.
46. Goto Y, Shinjo K, Kondo Y, Shen L, Toyota M, Suzuki H, Gao W, An B, Fujii M, Murakami H, Osada H, Taniguchi T, Usami N, Kondo M, Hasegawa Y, Shimokata K, Matsuo K, Hida T, Fujimoto N, Kishimoto T, Issa JP, and Sekido Y. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma. Cancer Res 69: 9073-9082, 2009.
47. Grafodatskaya D, Chung B, Szatmari P, and Weksberg R. Autism spectrum disorders and epigenetics. J Am Acad Child Adolesc Psychiatry 49: 794-809, 2010.
48. Griffiths E, and Gore S. MicroRNA: mIR-ly regulators of DNMT? Blood 113: 6269-6270, 2009.
49. Gutteridge JM, and Halliwell B. Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci 899: 136-147, 2000. (Pubitemid 30352782)
50. Haigis MC, and Guarente LP. Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction. Genes Dev 20: 2913-2921, 2006. (Pubitemid 44771725)
51. Handy DE, Castro R, and Loscalzo J. Epigenetic modifications: basic mechanisms and role in cardiovascular disease. Circulation 123: 2145-2156, 2011.
52. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100: 2153-2157, 1997. (Pubitemid 27500136)
53. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES, Slagboom PE, and Lumey LH. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA 105: 17046-17049, 2008.
54. Hiltunen MO, and Yla-Herttuala S. DNA methylation, smooth muscle cells, and atherogenesis. Arterioscler Thromb Vasc Biol 23: 1750-1753, 2003. (Pubitemid 37254858)
55. Huang T, Chen Y, Yang B, Yang J, Wahlqvist ML, and Li D. Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality. Clin Nutr 31: 448-454, 2012.
56. Huang Y, Zou Q, Song H, Song F, Wang L, Zhang G, and Shen X. A study of miRNAs targets prediction and experimental validation. Protein Cell 1: 979-986, 2010.
57. Illingworth R, and Bird A. CpG islands: "a rough guide." FEBS Lett 583: 1713-1720, 2009.
58. Ingrosso D, and Perna AF. Epigenetics in hyperhomocysteinemic states. A special focus on uremia. Biochim Biophys Acta 1790: 892-899, 2009.
59. Jaenisch R, and Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33 Suppl: 245-254, 2003. (Pubitemid 36278835)
60. Jenuwein T, and Allis CD. Translating the histone code. Science 293: 1074-1080, 2001. (Pubitemid 32758077)
61. John B, Sander C, and Marks D. Prediction of human microRNA targets. Methods Mol Biol 342: 101-113, 2006.
62. Johnson AB, Denko N, and Barton MC. Hypoxia induces a novel signature of chromatin modifications and global repression of transcription. Mutat Res 640: 174-179, 2008.
63. Jones DP. Redefining oxidative stress. Antioxid Redox Signal 8: 1865-1879, 2006. (Pubitemid 44726359)
64. Jones PA, and Takai D. The role of DNA methylation in mammalian epigenetics. Science 293: 1068-1070, 2001. (Pubitemid 32758075)
65. Jones SP, and Bolli R. The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol 40: 16-23, 2006. (Pubitemid 43012113)
66. Kaneda R, Takada S, Yamashita Y, Choi YL, Nonaka-Sarukawa M, Soda M, Misawa Y, Isomura T, Shimada K, and Mano H. Genome-wide histone methylation profile for heart failure. Genes Cells 14: 69-77, 2009.
67. Kawahara K, Kawabata H, Aratani S, and Nakajima T. Hyper nuclear acetylation (HNA) in proliferation, differentiation and apoptosis. Ageing Res Rev 2: 287-297, 2003. (Pubitemid 38340317)
68. Kawahara K, Watanabe S, Ohshima T, Soejima Y, Oishi T, Aratani S, Nakata M, Shibata M, Inoue K, Amano T, Fujii R, Yanai K, Hagiwara M, Fukamizu A, Maruyama I, and Nakajima T. Hypernuclear acetylation in atherosclerotic lesions and activated vascular smooth muscle cells. Biochem Biophys Res Commun 266: 417-424, 1999. (Pubitemid 30028683)
69. Kim GH, Ryan JJ, Marsboom G, and Archer SL. Epigenetic mechanisms of pulmonary hypertension. Pulm Circ 1: 347-356, 2011.
70. Kim J, Kim JY, Song KS, Lee YH, Seo JS, Jelinek J, Goldschmidt-Clermont PJ, and Issa JP. Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence. Biochim Biophys Acta 1772: 72-80, 2007. (Pubitemid 44960730)
71. Kim M, Long TI, Arakawa K, Wang R, Yu MC, and Laird PW. DNA methylation as a biomarker for cardiovascular disease risk. PLoS One 5: e9692, 2010.
72. Kim MS, Kondo T, Takada I, Youn MY, Yamamoto Y, Takahashi S, Matsumoto T, Fujiyama S, Shirode Y, Yamaoka I, Kitagawa H, Takeyama K, Shibuya H, Ohtake F, and Kato S. DNA demethylation in hormone-induced transcriptional derepression. Nature 461: 1007-1012, 2009.
73. Klug M, Heinz S, Gebhard C, Schwarzfischer L, Krause SW, Andreesen R, and Rehli M. Active DNA demethylation in human postmitotic cells correlates with activating histone modifications, but not transcription levels. Genome Biol 11: R63, 2010.
74. Kojda G, and Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 43: 562-571, 1999. (Pubitemid 29369255)
75. Kong Y, Tannous P, Lu G, Berenji K, Rothermel BA, Olson EN, and Hill JA. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113: 2579-2588, 2006. (Pubitemid 43948006)
76. Kreymborg K, Uchida S, Gellert P, Schneider A, Boettger T, Voswinckel R, Wietelmann A, Szibor M, Weissmann N, Ghofrani AH, Schermuly R, Schranz D, Seeger W, and Braun T. Identification of right heart-enriched genes in a murine model of chronic outflow tract obstruction. J Mol Cell Cardiol 49: 598-605, 2010.
77. Lalande M, and Calciano MA. Molecular epigenetics of Angelman syndrome. Cell Mol Life Sci 64: 947-960, 2007. (Pubitemid 46597759)
78. Laukkanen MO, Mannermaa S, Hiltunen MO, Aittomaki S, Airenne K, Janne J, and Yla-Herttuala S. Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. Arterioscler Thromb Vasc Biol 19: 2171-2178, 1999. (Pubitemid 29422250)
79. Li K, Blum Y, Verma A, Liu Z, Pramanik K, Leigh NR, Chun CZ, Samant GV, Zhao B, Garnaas MK, Horswill MA, Stanhope SA, North PE, Miao RQ, Wilkinson GA, Affolter M, and Ramchandran R. A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo. Blood 115: 133-139, 2010.
80. Ling C, and Groop L. Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes 58: 2718-2725, 2009.
81. Lund G, Andersson L, Lauria M, Lindholm M, Fraga MF, Villar-Garea A, Ballestar E, Esteller M, and Zaina S. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem 279: 29147-29154, 2004. (Pubitemid 38915787)
82. Luoma JS, Stralin P, Marklund SL, Hiltunen TP, Sarkioja T, and Yla-Herttuala S. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol 18: 157-167, 1998. (Pubitemid 28277591)
83. Lusis AJ. Atherosclerosis. Nature 407: 233-241, 2000.
84. Makar KW, and Wilson CB. DNA methylation is a nonredundant repressor of the Th2 effector program. J Immunol 173: 4402-4406, 2004. (Pubitemid 39280669)
85. Marsboom G, Wietholt C, Haney CR, Toth PT, Ryan JJ, Morrow E, Thenappan T, Bache-Wiig P, Piao L, Paul J, Chen CT, and Archer SL. Lung (1)(8)F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension. Am J Respir Crit Care Med 185: 670-679, 2012.
86. Mathiyalagan P, Chang L, Du XJ, and El-Osta A. Cardiac ventricular chambers are epigenetically distinguishable. Cell Cycle 9: 612-617, 2010.
87. McDonald OG, and Owens GK. Programming smooth muscle plasticity with chromatin dynamics. Circ Res 100: 1428-1441, 2007. (Pubitemid 46834755)
88. McDonald OG, Wamhoff BR, Hoofnagle MH, and Owens GK. Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. J Clin Invest 116: 36-48, 2006. (Pubitemid 43121789)
89. Mellott JK, Nick HS, Waters MF, Billiar TR, Geller DA, and Chesrown SE. Cytokine-induced changes in chromatin structure and in vivo footprints in the inducible NOS promoter. Am J Physiol Lung Cell Mol Physiol 280: L390-399, 2001.
90. Miller VM, and Duckles SP. Vascular actions of estrogens: functional implications. Pharmacol Rev 60: 210-241, 2008. (Pubitemid 351962010)
91. Miranda TB, and Jones PA. DNA methylation: the nuts and bolts of repression. J Cell Physiol 213: 384-390, 2007. (Pubitemid 47509717)
92. Mitro N, Godio C, De Fabiani E, Scotti E, Galmozzi A, Gilardi F, Caruso D, Vigil Chacon AB, and Crestani M. Insights in the regulation of cholesterol 7alpha-hydroxylase gene reveal a target for modulating bile acid synthesis. Hepatology 46: 885-897, 2007. (Pubitemid 47436134)
93. Movassagh M, Choy MK, Goddard M, Bennett MR, Down TA, and Foo RS. Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure. PLoS One 5: e8564, 2010.
94. Movassagh M, Choy MK, Knowles DA, Cordeddu L, Haider S, Down T, Siggens L, Vujic A, Simeoni I, Penkett C, Goddard M, Lio P, Bennett MR, and Foo RS. Distinct epigenomic features in end-stage failing human hearts. Circulation 124: 2411-2422, 2011.
95. Nanayakkara PW, Kiefte-de Jong JC, Stehouwer CD, van Ittersum FJ, Olthof MR, Kok RM, Blom HJ, van Guldener C, ter Wee PM, and Smulders YM. Association between global leukocyte DNA methylation, renal function, carotid intimamedia thickness and plasma homocysteine in patients with stage 2-4 chronic kidney disease. Nephrol Dial Transplant 23: 2586-2592, 2008.
96. Nedeljkovic ZS, Gokce N, and Loscalzo J. Mechanisms of oxidative stress and vascular dysfunction. Postgrad Med J 79: 195-199; quiz 198-200, 2003.
97. Noonan EJ, Place RF, Pookot D, Basak S, Whitson JM, Hirata H, Giardina C, and Dahiya R. miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene 28: 1714-1724, 2009.
98. O'Hagan HM, Wang W, Sen S, Destefano Shields C, Lee SS, Zhang YW, Clements EG, Cai Y, Van Neste L, Easwaran H, Casero RA, Sears CL, and Baylin SB. Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands. Cancer Cell 20: 606-619, 2011.
99. Ohtani K, Vlachojannis GJ, Koyanagi M, Boeckel JN, Urbich C, Farcas R, Bonig H, Marquez VE, Zeiher AM, and Dimmeler S. Epigenetic regulation of endothelial lineage committed genes in pro-angiogenic hematopoietic and endothelial progenitor cells. Circ Res 109: 1219-1229, 2011.
100. Okano M, Bell D, Haber D, and Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99: 247-257, 1999. (Pubitemid 29519904)
101. Ordovas JM, and Smith CE. Epigenetics and cardiovascular disease. Nat Rev Cardiol 7: 510-519, 2010.
102. Painter RC, Roseboom TJ, and Bleker OP. Prenatal exposure to the Dutch famine and disease in later life: an overview. Reprod Toxicol 20: 345-352, 2005. (Pubitemid 40949554)
103. Parikh VN, Jin RC, Rabello S, Gulbahce N, White K, Hale A, Cottrill KA, Shaik RS, Waxman AB, Zhang YY, Maron BA, Hartner JC, Fujiwara Y, Orkin SH, Haley KJ, Barabasi AL, Loscalzo J, and Chan SY. MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach. Circulation 125: 1520-1532, 2012.
104. Perini G, Diolaiti D, Porro A, and Della Valle G. In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation. Proc Natl Acad Sci USA 102: 12117-12122, 2005. (Pubitemid 41291138)
105. Pillai JB, Isbatan A, Imai S, and Gupta MP. Poly(ADPribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity. J Biol Chem 280: 43121-43130, 2005. (Pubitemid 43049278)
106. Pillai VB, Sundaresan NR, Kim G, Gupta M, Rajamohan SB, Pillai JB, Samant S, Ravindra PV, Isbatan A, and Gupta MP. Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J Biol Chem 285: 3133-3144, 2010.
107. Pizzolo F, Blom HJ, Choi SW, Girelli D, Guarini P, Martinelli N, Stanzial AM, Corrocher R, Olivieri O, and Friso S. Folic acid effects on s-adenosylmethionine, s-adenosylhomocysteine, and DNA methylation in patients with intermediate hyperhomocysteinemia. J Am Coll Nutr 30: 11-18, 2011.
108. Pons D, de Vries FR, van den Elsen PJ, Heijmans BT, Quax PH, and Jukema JW. Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease. Eur Heart J 30: 266-277, 2009.
109. Post WS, Goldschmidt-Clermont PJ, Wilhide CC, Heldman AW, Sussman MS, Ouyang P, Milliken EE, and Issa JP. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 43: 985-991, 1999. (Pubitemid 29413198)
110. Prokhortchouk A, Hendrich B, Jorgensen H, Ruzov A, Wilm M, Georgiev G, Bird A, and Prokhortchouk E. The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev 15: 1613-1618, 2001. (Pubitemid 32702582)
111. Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ, and Fernandez-Hernando C. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328: 1570-1573, 2010.
112. Redon J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, and Saez GT. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41: 1096-1101, 2003. (Pubitemid 36548609)
113. Rees WD, Hay SM, Brown DS, Antipatis C, and Palmer RM. Maternal protein deficiency causes hypermethylation of DNA in the livers of rat fetuses. J Nutr 130: 1821-1826, 2000. (Pubitemid 30451074)
114. Rexhaj E, Bloch J, Jayet PY, Rimoldi SF, Dessen P, Mathieu C, Tolsa JF, Nicod P, Scherrer U, and Sartori C. Fetal programming of pulmonary vascular dysfunction in mice: role of epigenetic mechanisms. Am J Physiol Heart Circ Physiol 301: H247-252, 2011.
115. Robb GB, Carson AR, Tai SC, Fish JE, Singh S, Yamada T, Scherer SW, Nakabayashi K, and Marsden PA. Posttranscriptional regulation of endothelial nitric-oxide synthase by an overlapping antisense mRNA transcript. J Biol Chem 279: 37982-37996, 2004. (Pubitemid 39195514)
116. Rodriguez-Paredes M, and Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med 17: 330-339, 2011.
117. Ruberg FL, and Loscalzo J. Prothrombotic determinants of coronary atherothrombosis. Vasc Med 7: 289-299, 2002. (Pubitemid 36469493)
118. Saha A, Wittmeyer J, and Cairns BR. Chromatin remodelling: the industrial revolution of DNA around histones. Nat Rev Mol Cell Biol 7: 437-447, 2006. (Pubitemid 44050097)
119. Sharma P, Kumar J, Garg G, Kumar A, Patowary A, Karthikeyan G, Ramakrishnan L, Brahmachari V, and Sengupta S. Detection of altered global DNA methylation in coronary artery disease patients. DNA Cell Biol 27: 357-365, 2008. (Pubitemid 351969854)
120. Sharma P, Senthilkumar RD, Brahmachari V, Sundaramoorthy E, Mahajan A, Sharma A, and Sengupta S. Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids Health Dis 5: 1, 2006.
121. Shilo S, Roy S, Khanna S, and Sen CK. Evidence for the involvement of miRNA in redox regulated angiogenic response of human microvascular endothelial cells. Arterioscler Thromb Vasc Biol 28: 471-477, 2008.
122. Shirodkar AV, and Marsden PA. Epigenetics in cardiovascular disease. Curr Opin Cardiol 26: 209-215, 2011.
123. Smolarek I, Wyszko E, Barciszewska AM, Nowak S, Gawronska I, Jablecka A, and Barciszewska MZ. Global DNA methylation changes in blood of patients with essential hypertension. Med Sci Monit 16: CR149-155, 2010.
124. Stein AB, Jones TA, Herron TJ, Patel SR, Day SM, Noujaim SF, Milstein ML, Klos M, Furspan PB, Jalife J, and Dressler GR. Loss of H3K4 methylation destabilizes gene expression patterns and physiological functions in adult murine cardiomyocytes. J Clin Invest 121: 2641-2650, 2011.
125. Stenvinkel P, Karimi M, Johansson S, Axelsson J, Suliman M, Lindholm B, Heimburger O, Barany P, Alvestrand A, Nordfors L, Qureshi AR, Ekstrom TJ, and Schalling M. Impact of inflammation on epigenetic DNA methylation-a novel risk factor for cardiovascular disease? J Intern Med 261: 488-499, 2007. (Pubitemid 46587721)
126. Svedruzić Z . Dnmt1 structure and function. Prog Mol Biol Transl Sci 101: 221-254, 2011.
127. Tanno M, Kuno A, Horio Y, and Miura T. Emerging beneficial roles of sirtuins in heart failure. Basic Res Cardiol 107: 273, 2012.
128. Tobi EW, Heijmans BT, Kremer D, Putter H, Delemarre-van de Waal HA, Finken MJ, Wit JM, and Slagboom PE. DNA methylation of IGF2, GNASAS, INSIGF and LEP and being born small for gestational age. Epigenetics 6: 171-176, 2011.
129. Tobi EW, Lumey LH, Talens RP, Kremer D, Putter H, Stein AD, Slagboom PE, and Heijmans BT. DNA methylation differences after exposure to prenatal famine are common and timing-and sex-specific. Hum Mol Genet 18: 4046-4053, 2009.
130. Topkara VK, and Mann DL. Role of microRNAs in cardiac remodeling and heart failure. Cardiovasc Drugs Ther 25: 171-182, 2011.
131. Tsutsumi YM, Horikawa YT, Jennings MM, Kidd MW, Niesman IR, Yokoyama U, Head BP, Hagiwara Y, Ishikawa Y, Miyanohara A, Patel PM, Insel PA, Patel HH, and Roth DM. Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning. Circulation 118: 1979-1988, 2008.
132. Turunen MP, Aavik E, and Yla-Herttuala S. Epigenetics and atherosclerosis. Biochim Biophys Acta 1790: 886-891, 2009.
133. Ungvari Z, Csiszar A, Edwards JG, Kaminski PM, Wolin MS, Kaley G, and Koller A. Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 23: 418-424, 2003. (Pubitemid 36337217)
134. Venkov CD, Rankin AB, and Vaughan DE. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation 94: 727-733, 1996. (Pubitemid 26289229)
135. Wang YS, Chou WW, Chen KC, Cheng HY, Lin RT, and Juo SH. MicroRNA-152 mediates DNMT1-regulated DNA methylation in the estrogen receptor alpha gene. PLoS One 7: e30635, 2012.
136. Wenger RH, Kvietikova I, Rolfs A, Camenisch G, and Gassmann M. Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxiainducible factor-1 DNA-binding site. Eur J Biochem 253: 771-777, 1998. (Pubitemid 28223547)
137. Wilcox JN, Subramanian RR, Sundell CL, Tracey WR, Pollock JS, Harrison DG, and Marsden PA. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol 17: 2479-2488, 1997. (Pubitemid 28015984)
138. Xu XF, Ma XL, Shen Z, Wu XL, Cheng F, and Du LZ. Epigenetic regulation of the endothelial nitric oxide synthase gene in persistent pulmonary hypertension of the newborn rat. J Hypertens 28: 2227-2235, 2010.
139. Yan MS, Matouk CC, and Marsden PA. Epigenetics of the vascular endothelium. J Appl Physiol 109: 916-926, 2010.
140. Yusuf S, Dagenais G, Pogue J, Bosch J, and Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342: 154-160, 2000. (Pubitemid 30051646)
141. Zaina S, Lindholm MW, and Lund G. Nutrition and aberrant DNA methylation patterns in atherosclerosis: more than just hyperhomocysteinemia? J Nutr 135: 5-8, 2005. (Pubitemid 40094312)
142. Zhang Y, and Reinberg D. Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev 15: 2343-2360, 2001. (Pubitemid 32899739)